Released on: December 5, 2007, 10:01 pm

Press Release Author: Bioinformatics Institute of India

Industry: Education

Press Release Summary: Admissions open

Press Release Body: Bioinformatics Institute of India, as a part of its offerings to
Pharma companies announces invitation for nomination of professionals for its
January 2008 Batch - Industry Program in Pharma Regulatory Affairs. This program is
specially meant for professionals working in the Pharmaceutical Industry and willing
to specialize in the Pharma Regulatory Affairs . The program will have modules
namely: Pharma Regulation Practices and Procedure, Pharma Patents, IPR and
Regulation, Clinical Trials and Regulation, Pharma Regulation in USA, European
Union , Good Manufacturing Practices, Quality Assurance and Regulation, Regulatory
Compliance for Pharma and Biotech Products and Research Study. The program is
delivered via BII's proven distance participation methodology which includes
dispatch of electronic lectures, study material and assignments, online support and
interaction via BII Blog, placement support and all India exams . The past batches
of this program have participants from reputed companies like Stride Arcolabs,
Biocon, Ranbaxy, Dabur, Pfizer, Dr Reddy Labs, Vimta Labs, Novartis etc. So far
more than 1000 professionals have participated in BII's Pharma Regulatory Affairs
program. Both group nomination from corporate HR Departments and individual
nomination from professionals is invited. Highly interested BPharma / DPharma
students in their final years are also welcome. Further details about the program
are available at www.bii.in/biodlp, Last date to apply is January 31st 2008



Web Site: http://www.bii.in

Contact Details: Bioinformatics Institute of India
C 56 A/28 Sec 62, Noida - 201301
www.bii.in, journal@bioinformaticscntre.org
Tel: 0120- 4320801, 802,